The Gross Margin of Kyorin Pharmaceutical Co Ltd (4569.T) is 45.77%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2025-03-31 | 45.77% |
| 2024-03-31 | 43.01% |
| 2023-03-31 | 44.29% |
| 2022-03-31 | 46.85% |
| 2021-03-31 | 50.17% |
| 2020-03-31 | 51.86% |
| 2019-03-31 | 50.53% |
| 2018-03-31 | 55.65% |
| 2017-03-31 | 55.93% |
| 2016-03-31 | 60.36% |